These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24151192)

  • 1. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.
    Karimi M; Moerlein SM; Videen TO; Su Y; Flores HP; Perlmutter JS
    Mov Disord; 2013 Dec; 28(14):2002-6. PubMed ID: 24151192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
    Berman BD; Hallett M; Herscovitch P; Simonyan K
    Brain; 2013 Dec; 136(Pt 12):3645-58. PubMed ID: 24148273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The direct basal ganglia pathway is hyperfunctional in focal dystonia.
    Simonyan K; Cho H; Hamzehei Sichani A; Rubien-Thomas E; Hallett M
    Brain; 2017 Dec; 140(12):3179-3190. PubMed ID: 29087445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?
    Karimi M; Moerlein SM; Videen TO; Luedtke RR; Taylor M; Mach RH; Perlmutter JS
    Mov Disord; 2011 Jan; 26(1):100-6. PubMed ID: 20960437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
    Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
    J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
    Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
    Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects.
    Robertson CL; Ishibashi K; Mandelkern MA; Brown AK; Ghahremani DG; Sabb F; Bilder R; Cannon T; Borg J; London ED
    J Neurosci; 2015 Apr; 35(15):5990-7. PubMed ID: 25878272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.
    Abi-Dargham A; Martinez D; Mawlawi O; Simpson N; Hwang DR; Slifstein M; Anjilvel S; Pidcock J; Guo NN; Lombardo I; Mann JJ; Van Heertum R; Foged C; Halldin C; Laruelle M
    J Cereb Blood Flow Metab; 2000 Feb; 20(2):225-43. PubMed ID: 10698059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
    Karlsson P; Farde L; Halldin C; Swahn CG; Sedvall G; Foged C; Hansen KT; Skrumsager B
    Psychopharmacology (Berl); 1993; 113(2):149-56. PubMed ID: 7855175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PET.
    Rosa-Neto P; Doudet DJ; Cumming P
    Neuroimage; 2004 Jul; 22(3):1076-83. PubMed ID: 15219579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease progression. PET and clinical observations.
    Andrews TC; Weeks RA; Turjanski N; Gunn RN; Watkins LH; Sahakian B; Hodges JR; Rosser AE; Wood NW; Brooks DJ
    Brain; 1999 Dec; 122 ( Pt 12)():2353-63. PubMed ID: 10581228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
    Hagelberg N; Forssell H; Rinne JO; Scheinin H; Taiminen T; Aalto S; Luutonen S; Någren K; Jääskeläinen S
    Pain; 2003 Jan; 101(1-2):149-54. PubMed ID: 12507709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography shows reduced striatal dopamine D1 but not D2 receptors in juvenile neuronal ceroid lipofuscinosis.
    Rinne JO; Ruottinen HM; Någren K; Aberg LE; Santavuori P
    Neuropediatrics; 2002 Jun; 33(3):138-41. PubMed ID: 12200743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD.
    Kemppainen N; Ruottinen H; Nâgren K; Rinne JO
    Neurology; 2000 Jul; 55(2):205-9. PubMed ID: 10908891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
    Guo N; Hwang DR; Lo ES; Huang YY; Laruelle M; Abi-Dargham A
    Neuropsychopharmacology; 2003 Sep; 28(9):1703-11. PubMed ID: 12813475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
    Okita K; Morales AM; Dean AC; Johnson MC; Lu V; Farahi J; Mandelkern MA; London ED
    Mol Psychiatry; 2018 May; 23(5):1320-1327. PubMed ID: 28894300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Psychopharmacology (Berl); 2006 Mar; 185(1):29-35. PubMed ID: 16395606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.
    Cannon DM; Klaver JM; Peck SA; Rallis-Voak D; Erickson K; Drevets WC
    Neuropsychopharmacology; 2009 Apr; 34(5):1277-87. PubMed ID: 18946469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET.
    Foged C; Halldin C; Swahn CG; Ginovart N; Karlsson P; Lundkvist C; Farde L
    Nucl Med Biol; 1998 Jul; 25(5):503-8. PubMed ID: 9720669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.